ARCHIVES

NCI Spent $381.2 Million On PR From 2006 to 2012, Vastly Outspending Other NIH, FDA Units

This article is from The Cancer Letter archive.

Vol. 39 No. 09 | March 1, 2013

Download PDF Visit The Full Archive

Related Articles

“Perhaps the most troubling finding was a broad dissatisfaction with the general ethos within the intramural community.”

July 14, 1995

ACS Reorganization Plans, Policy Changes Discussed By Board

November 29, 1991

Herceptin Reduces Recurrence In Early HER2+ Breast Cancer

September 30, 2005

In Brief: Healy To Use 1 Percent Transfer Authority For TB Research; Zoon Heads FDA’s CBER

March 20, 1992

NCI To Seek Proposals For Less Invasive Detection, Diagnosis, Treatment Technologies

July 3, 1998

Scientists, Advocates Voice Objections To von Eschenbach’s Conflicts, 2015.

November 22, 2006